207 related articles for article (PubMed ID: 20651198)
21. [No detectable nephrotoxic side effect using a dimer, non-ionic contrast media in cerebral perfusion computed tomography in case of suspected brain ischemia].
Petrik M; Weigel C; Kirsch M; Hosten N
Rofo; 2005 Sep; 177(9):1242-9. PubMed ID: 16123870
[TBL] [Abstract][Full Text] [Related]
22. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
Davenport MS; Khalatbari S; Dillman JR; Cohan RH; Caoili EM; Ellis JH
Radiology; 2013 Apr; 267(1):94-105. PubMed ID: 23360737
[TBL] [Abstract][Full Text] [Related]
23. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
[TBL] [Abstract][Full Text] [Related]
24. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
[TBL] [Abstract][Full Text] [Related]
25. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.
Lencioni R; Fattori R; Morana G; Stacul F
Acta Radiol; 2010 Sep; 51(7):741-50. PubMed ID: 20707658
[TBL] [Abstract][Full Text] [Related]
26. Glomerular filtration rate in evaluation of the effect of iodinated contrast media on renal function.
Becker J; Babb J; Serrano M
AJR Am J Roentgenol; 2013 Apr; 200(4):822-6. PubMed ID: 23521455
[TBL] [Abstract][Full Text] [Related]
27. Is the use of intravenous contrast material truly safe in patients with impaired renal function?
Cohen MD
Radiology; 2009 May; 251(2):613; author reply 613-4. PubMed ID: 19401587
[No Abstract] [Full Text] [Related]
28. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.
Pahade JK; LeBedis CA; Raptopoulos VD; Avigan DE; Yam CS; Kruskal JB; Pedrosa I
AJR Am J Roentgenol; 2011 May; 196(5):1094-101. PubMed ID: 21512075
[TBL] [Abstract][Full Text] [Related]
29. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
Terrenato I; Sperati F; Musicco F; Pozzi AF; di Turi A; Caterino M; de Lutio di Castelguidone E; Setola SV; Bellomi M; Neumaier CE; Conti L; Cigliana G; Merola R; Antenucci A; Orlandi G; Giordano A; Barba M; Canitano S
J Cell Physiol; 2018 Mar; 233(3):2572-2580. PubMed ID: 28777459
[TBL] [Abstract][Full Text] [Related]
30. Negative effects of iodine-based contrast agent on renal function in patients with moderate reduced renal function hospitalized for COVID-19.
Kistner A; Tamm C; Svensson AM; Beckman MO; Strand F; Sköld M; Nyrén S
BMC Nephrol; 2021 Aug; 22(1):297. PubMed ID: 34465289
[TBL] [Abstract][Full Text] [Related]
31. Risk of Acute Kidney Injury Following Contrast-enhanced CT in Hospitalized Pediatric Patients: A Propensity Score Analysis.
Gilligan LA; Davenport MS; Trout AT; Su W; Zhang B; Goldstein SL; Dillman JR
Radiology; 2020 Mar; 294(3):548-556. PubMed ID: 31961262
[TBL] [Abstract][Full Text] [Related]
32. Nephropathy in critically Ill patients without preexisting renal disease.
Polena S; Yang S; Alam R; Gricius J; Gupta JR; Badalova N; Chuang P; Gintautas J; Conetta R
Proc West Pharmacol Soc; 2005; 48():134-5. PubMed ID: 16416679
[TBL] [Abstract][Full Text] [Related]
33. Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
Werner S; Bez C; Hinterleitner C; Horger M
PLoS One; 2020; 15(5):e0233433. PubMed ID: 32437415
[TBL] [Abstract][Full Text] [Related]
34. [Intravenous contrast medium application in elderly patients -- evaluation of Iopentol (Imagopaque 300)].
Rathsmann P; Jacobs GF; Müller RD
Rofo; 2004 Dec; 176(12):1826-31. PubMed ID: 15573295
[TBL] [Abstract][Full Text] [Related]
35. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
36. Administration of contrast media just before cisplatin-based chemotherapy increases cisplatin-induced nephrotoxicity.
Sendur MA; Aksoy S; Yaman S; Arik Z; Tugba Kos F; Akinci MB; Civelek B; Yildirim Ozdemir N; Uncu D; Zengin N
J BUON; 2013; 18(1):274-80. PubMed ID: 23613416
[TBL] [Abstract][Full Text] [Related]
37. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
Huber W; Ilgmann K; Page M; Hennig M; Schweigart U; Jeschke B; Lutilsky L; Weiss W; Salmhofer H; Classen M
Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
[TBL] [Abstract][Full Text] [Related]
38. Incidence of nonconfounded post-computed tomography acute kidney injury in hospitalized patients with stable renal function receiving intravenous iodinated contrast material.
Moore A; Dickerson E; Dillman JR; Vummidi D; Kershaw DB; Khalatbari S; Davenport MS
Curr Probl Diagn Radiol; 2014; 43(5):237-41. PubMed ID: 24909428
[TBL] [Abstract][Full Text] [Related]
39. Low-contrast dose protection protocol for diagnostic computed tomography in patients at high-risk for contrast-induced nephropathy.
Kidoh M; Nakaura T; Awai K; Matsunaga Y; Tanoue K; Harada K; Uemura S; Yamashita Y
J Comput Assist Tomogr; 2013; 37(2):289-96. PubMed ID: 23493222
[TBL] [Abstract][Full Text] [Related]
40. Is Intravenous Administration of Iodixanol Associated with Increased Risk of Acute Kidney Injury, Dialysis, or Mortality? A Propensity Score-adjusted Study.
McDonald JS; McDonald RJ; Williamson EE; Kallmes DF
Radiology; 2017 Nov; 285(2):414-424. PubMed ID: 28708022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
